CorVel Co. (NASDAQ:CRVL) Shares Acquired by Algert Global LLC

Algert Global LLC boosted its stake in CorVel Co. (NASDAQ:CRVL) by 202.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,649 shares of the business services provider’s stock after acquiring an additional 65,365 shares during the period. Algert Global LLC owned 0.19% of CorVel worth $10,864,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. LGT Financial Advisors LLC raised its stake in shares of CorVel by 200.0% in the 4th quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider’s stock valued at $28,000 after purchasing an additional 170 shares in the last quarter. Comerica Bank raised its stake in CorVel by 197.6% during the fourth quarter. Comerica Bank now owns 25,623 shares of the business services provider’s stock valued at $2,851,000 after buying an additional 17,013 shares in the last quarter. Voleon Capital Management LP bought a new position in CorVel during the 4th quarter worth approximately $846,000. Northern Trust Corp grew its position in shares of CorVel by 210.8% in the 4th quarter. Northern Trust Corp now owns 379,743 shares of the business services provider’s stock worth $42,250,000 after acquiring an additional 257,561 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of CorVel by 192.5% in the 4th quarter. The Manufacturers Life Insurance Company now owns 14,867 shares of the business services provider’s stock valued at $1,654,000 after acquiring an additional 9,785 shares during the last quarter. 51.36% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Steven J. Hamerslag sold 10,000 shares of the stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the sale, the director now owns 314,000 shares of the company’s stock, valued at $38,772,720. This trade represents a 3.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Brandon O’brien sold 1,523 shares of CorVel stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $119.56, for a total transaction of $182,089.88. Following the completion of the sale, the chief financial officer now owns 17,142 shares in the company, valued at approximately $2,049,497.52. This represents a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,723 shares of company stock valued at $5,757,140 over the last three months. Company insiders own 47.57% of the company’s stock.

CorVel Stock Performance

NASDAQ CRVL opened at $112.03 on Friday. The firm has a market capitalization of $5.75 billion, a PE ratio of 65.90 and a beta of 0.94. CorVel Co. has a one year low of $76.53 and a one year high of $128.61. The company has a 50-day simple moving average of $110.38 and a 200-day simple moving average of $115.77.

CorVel (NASDAQ:CRVL) last posted its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Analysts Set New Price Targets

Separately, StockNews.com upgraded CorVel from a “hold” rating to a “buy” rating in a research note on Friday, April 18th.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.